Home > Insider Trading > Filing (0001225208-17-010828)

Filing Details

Accession Number:: 0001225208-17-010828
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-06-02 18:17:36
Reporting Period:: 2017-05-31

Filing Date:: 2017-06-02
Accepted Time:: 2017-06-02 18:17:36
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1269021	Portola Pharmaceuticals Inc	PTLA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1250409	W Jeffrey Bird	755 Page Mill Road, Suite A-200 Palo Alto CA 94304-1005		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-06-01	8,800	$31.85	45,402	No	4	P	Indirect	By Ltd Partnership (NEST)
Common Stock	Disposition	2017-05-31	147,523	$0.00	810,968	No	4	J	Indirect	By Ltd Partnership (SHV)
Common Stock	Acquisiton	2017-06-01	110,642	$31.85	921,610	No	4	P	Indirect	By Ltd Partnership (SHV)

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Ltd Partnership (NEST)
No	4	J	Indirect	By Ltd Partnership (SHV)
No	4	P	Indirect	By Ltd Partnership (SHV)

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	3,000	Direct
Common Stock	59,053	Indirect	By Trust (Trustees)

Footnotes

In connection with the Liquidation, the reporting person entered into an agreement with the Limited Partner to repurchase 8,800 Distributed Common Shares from the Limited Partner at a purchase price equal to the average of the mean between the closing bid and ask prices over the ninety (90)-day period ended March 31, 2017.
Shares held by a limited partnership of which the reporting person is a trustee of a trust which is the General Partner. The reporting person disclaims beneficial ownership of these shares except as to the reporting person's pecuniary interest therein.
On May 31, 2017, a limited partner (the "Limited Partner") of Sutter Hill Ventures, a California Limited Partnership ("SHV") liquidated its interest in SHV in return for its ratable share of the holdings of SHV, resulting in SHV's disposition to the Limited Partner of 147,523 shares (the "Distributed Common Shares") of the Issuer's common stock (the "Liquidation").
Shares held by SHV. The reporting person is a managing director and member of the management committee of the general partner of SHV. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.
In connection with the Liquidation, SHV entered into an agreement with the Limited Partner to repurchase 110,642 Distributed Common Shares from the Limited Partner at a purchase price equal to the average of the mean between the closing bid and ask prices over the ninety (90)-day period ended March 31, 2017.
Shares held by a trust of which the reporting person is a trustee. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.